Financials
Financial year 2025
Dr. Erika Peeters, neuroloog-revalidatiearts from Sint-Pieters-Leeuw, company number BE0860752858, closed financial year 2025 with a result of € 121,451 after tax. For that financial year Dr. Erika Peeters, neuroloog-revalidatiearts recorded a gross margin of € 180,267 and equity of € 619,674. Compared with financial year 2024, the result moved from € 114,398 to € 121,451. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 619,674
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 121,451
▲ 6% vs 2024
Profit after tax over the fiscal year.
€ 599,502
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 53,801 paid out
44 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 16,666
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,218
▼ 70% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,136
▼ 40% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 170,623 | € 146,879 | € 168,656 | € 180,267 | ▲ 7% |
| Profit after taxes | € 102,202 | € 80,080 | € 114,398 | € 121,451 | ▲ 6% |
| Equity | € 485,749 | € 502,912 | € 552,024 | € 619,674 | ▲ 12% |
| Total debts | € 60,524 | € 78,597 | € 101,334 | € 74,155 | ▼ 27% |
| Cash | € 438,827 | € 402,036 | € 414,053 | € 599,502 | ▲ 45% |
| Land & buildings | € 17,850 | € 0 | - | - | |
| Retained profit | € 396,779 | € 413,942 | € 463,054 | € 530,704 | ▲ 15% |
| Dividend | € 38,990 | € 62,918 | € 65,286 | € 53,801 | ▼ 18% |
| Balance sheet total | € 546,273 | € 581,508 | € 653,358 | € 693,828 | ▲ 6% |
Key figures of Dr. Erika Peeters, neuroloog-revalidatiearts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Erika Peeters, neuroloog-revalidatiearts the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Erika Peeters, neuroloog-revalidatiearts?
What happened at Dr. Erika Peeters, neuroloog-revalidatiearts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 121,451 (▲ 6% vs 2024). Source: NBB ↗
- New establishment in Sint-Pieters-Leeuw. KBO
- Start of the company according to the CBE. KBO
- Erika Peeters became a director. NBB
In short
From € 102,202 profit in 2022 to € 121,451 profit in 2025.
Paid € 170,046 in corporate taxes since 2022.
Best year ever: 2025, with € 121,451 profit.
Paid out € 220,994 in dividends to the owners in total.
Management
Behind Dr. Erika Peeters, neuroloog-revalidatiearts is Erika Peeters.
Directors
According to the 2025 annual accounts
Erika Peeters
Director
since 2003
Establishments
Establishment units
Physical locations of this company
Victor Nonnemanstraat 16
1600 Sint-Pieters-Leeuw
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0860.752.858
- VAT number
- BE 0860.752.858
- Registered office
- Victor Nonnemanstraat 16, 1600 Sint-Pieters-Leeuw
- Names & denominations
- Dr. Erika Peeters, neuroloog-revalidatiearts
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 September 2003
- Peppol
- Active · Active since 5 Jul 2026